Quality and Safety
The FDA is recommending surveillance of Bell’s palsy after four Moderna trial participants developed the temporary facial paralysis.
HIMSS President and CEO Hal Wolf discusses 2020 success stories introduced by HIMSS this year with the aim of improving healthcare, including the global consortium for eHealth interoperability and digital health indicators.
FDA has issued emergency use authorization for an over-the-counter COVID-19 test that does not require a prescription.
A critical care nurse in New York City was the first person in the United States to receive the new Pfizer-BioNTech vaccine this morning.
Approval means vaccine distribution would be on Operation Warp Speed’s schedule for distribution by mid-month.
The Strategic National Stockpile is ready to supply states and hospitals, officials say.
A circular medical device industry is established on resource conservation, efficiency and cycles of reuse and material recovery.
Cerner's Hans Buitendijk, EHRA executive committee chair, and Foothold's David Bucciferro, committee vice chair, discuss the role of the association's COVID-19 Task Force in helping provider customers.
In the United States, Pfizer will have its vaccine review with the FDA tomorrow, December 10.
Dr. Suliman Alomran, medical informatics lecturer at the College of Medicine, King Saud University, details the Saudi response to COVID-19 and the digital platforms that will be adopted long after the pandemic.